SU1565027A1 - Inactivating agent of the west nile virus - Google Patents

Inactivating agent of the west nile virus

Info

Publication number
SU1565027A1
SU1565027A1 SU4494077/13A SU4494077A SU1565027A1 SU 1565027 A1 SU1565027 A1 SU 1565027A1 SU 4494077/13 A SU4494077/13 A SU 4494077/13A SU 4494077 A SU4494077 A SU 4494077A SU 1565027 A1 SU1565027 A1 SU 1565027A1
Authority
SU
USSR - Soviet Union
Prior art keywords
west nile
nile virus
inactivating agent
agent
haloperidol
Prior art date
Application number
SU4494077/13A
Other languages
Russian (ru)
Inventor
В.И. Вотяков
Н.П. Мишаева
А.А. Згировская
И.К. Зубович
И.А. Азарова
Original Assignee
Белорусский научно-исследовательский институт эпидемиологии и микробиологии
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Белорусский научно-исследовательский институт эпидемиологии и микробиологии filed Critical Белорусский научно-исследовательский институт эпидемиологии и микробиологии
Priority to SU4494077/13A priority Critical patent/SU1565027A1/en
Application granted granted Critical
Publication of SU1565027A1 publication Critical patent/SU1565027A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FIELD: virology. SUBSTANCE: agent used for inactivation of the West Nile virus is haloperidol. Proposed drug is used as antiviral preparation against viruses showing pathogenicity in human. EFFECT: increased effectiveness of agent.
SU4494077/13A 1988-08-29 1988-08-29 Inactivating agent of the west nile virus SU1565027A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4494077/13A SU1565027A1 (en) 1988-08-29 1988-08-29 Inactivating agent of the west nile virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4494077/13A SU1565027A1 (en) 1988-08-29 1988-08-29 Inactivating agent of the west nile virus

Publications (1)

Publication Number Publication Date
SU1565027A1 true SU1565027A1 (en) 1996-05-20

Family

ID=60529171

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4494077/13A SU1565027A1 (en) 1988-08-29 1988-08-29 Inactivating agent of the west nile virus

Country Status (1)

Country Link
SU (1) SU1565027A1 (en)

Similar Documents

Publication Publication Date Title
MY117892A (en) Therapeutic compounds
IL78553A (en) Therapeutic compositions of phosphonylmethoxyalkyl adenines
DE60239394D1 (en) ONCOLYTIC VIRUS THERAPY
GR1002767B (en) Insecticidal composition for treating and protecting domestic an
CA2293470A1 (en) Benzimidazole derivatives
RU94022480A (en) Method of hepatitis treatment, composition enhancing in vivo inactivation of hepatitis virus c, preparation for hepatitis c treatment
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
ES2176232T3 (en) ADEQUATE VACCINE TO BE USED IN THE PREVENTION AND TREATMENT OF INFECTION WITH HELICOBACTER.
UA29429C2 (en) Pharmaceutical composition for treatment of viral infections, method for preparation of composition, method for treatment or prophylaxis of aids in human
ATE175873T1 (en) OTHER INDOLE DERIVATIVES WITH ANTIVIRAL EFFECT
ES2123048T3 (en) ANTIVIRIC NUCLEOSID ANALOGS.
AP9801286A0 (en) Therapeutic compounds.
NO970847L (en) 2- [Amino-6- (cyclopropylamino) -9H-purin-9-yl] -2-cyclopenten-1-methanol succinate as anti-viral agent
DK178188D0 (en) ANTIVIRUS AGENT
SU1565027A1 (en) Inactivating agent of the west nile virus
ITMI913493A0 (en) DEVICE FOR DISINFECTION OR IMMUNIZATION OF AREAS OF THE HUMAN BODY EXPOSED TO CONTAGION BY GERMS, BACTERIA AND VIRUSES
DE69925312D1 (en) BUPROPION FOR THE TREATMENT OF VIRAL DISEASES
EP0642793A4 (en) Apoptosis inducer.
GR3024236T3 (en) Use of leukoregulin for the treatment of animals infected with an envelope-virus
ATE26267T1 (en) PYRIMIDINE DERIVATIVES, EQUIPPED WITH ANTIVIRAL ACTION.
ATE137968T1 (en) USE OF L-2-OXOTHIAZOLIDINE-4-CARBOXYLATE FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF LATENT HIV INFECTIONS
RU94045140A (en) Pharmaceutical composition for prophylaxis and treatment of viral diseases, method of its preparing and use of bradykinin antagonist or its physiologically tolerant salt as agent for prophylaxis and treatment of viral diseases
BR9710206A (en) Use of an interleukin-8 agent and antiviral pharmaceutical formulation
CA2193665A1 (en) Benzimidazole derivatives for the treatment and prophylaxis of virus infections
RU98117264A (en) METHOD FOR INHIBITING HUMAN IMMUNO DEFICIENCY VIRUS AND OTHER VIRUSES IN HUMAN BLOOD PLASMA WITH PRESERVATION OF FUNCTIONAL ACTIVITY OF BLOOD PLASMA PROTEINS